10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Calstrux™ from Ireland
Issued January 26, 2006 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardR0 R03127 (January 26, 2006)
Tariff classification
HTS codes: 3004.90.9190
Headings: 3004
Product description
The subject product, Calstrux™, formerly known as Stryker® TCP Putty (see New York Ruling Letter R01013, dated November 9, 2004), is a bone-void filler that is used as a graft extender for both acute and delayed/non-union fractures, total joint revisions, and spine fusions. In its condition as imported, the product consists of granules composed of a mixture of porous beta-tricalcium phosphate (ß-TCP) and carboxymethylcellulose sodium (CMC). Prior to actual use (i.e., subsequent to importation), the product is reconstituted with saline or water for injection (WFI) to form a putty-type mass, which provides improved handling properties and retention at the implant site. Calstrux™ is intended to be gently packed into bony voids or gaps of the skeletal system (e.g., the extremities, spine, and pelvis). Following placement in the bony void or gap, the tricalcium phosphate “scaffold” is resorbed, and replaced with bone during the healing process. [The CMC provides temporary (~24 hrs.) cohesive properties during handling and implantation, and is replaced by blood.] Calstrux™ is supplied in (measured-dose) quantities of 5cc, 10cc, or 15cc, put up in small bottles with removable caps.
CBP rationale
The applicable subheading for Calstrux™, imported put up in small bottles in the aforementioned (measured-dose) quantities, will be 3004.90.9190, Harmonized Tariff of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Other.
Full text
NY R03127 January 26, 2006 CLA-2-30:RR:NC:2:238 R03127 CATEGORY: Classification TARIFF NO.: 3004.90.9190 Mr. Matthew Piccirilli Stryker Biotech 35 South Street Hopkinton, MA 01748 RE: The tariff classification of Calstrux™ from Ireland Dear Mr. Piccirilli: In your letter dated January 18, 2006, you requested a tariff classification ruling. The subject product, Calstrux™, formerly known as Stryker® TCP Putty (see New York Ruling Letter R01013, dated November 9, 2004), is a bone-void filler that is used as a graft extender for both acute and delayed/non-union fractures, total joint revisions, and spine fusions. In its condition as imported, the product consists of granules composed of a mixture of porous beta-tricalcium phosphate (ß-TCP) and carboxymethylcellulose sodium (CMC). Prior to actual use (i.e., subsequent to importation), the product is reconstituted with saline or water for injection (WFI) to form a putty-type mass, which provides improved handling properties and retention at the implant site. Calstrux™ is intended to be gently packed into bony voids or gaps of the skeletal system (e.g., the extremities, spine, and pelvis). Following placement in the bony void or gap, the tricalcium phosphate “scaffold” is resorbed, and replaced with bone during the healing process. [The CMC provides temporary (~24 hrs.) cohesive properties during handling and implantation, and is replaced by blood.] Calstrux™ is supplied in (measured-dose) quantities of 5cc, 10cc, or 15cc, put up in small bottles with removable caps. The applicable subheading for Calstrux™, imported put up in small bottles in the aforementioned (measured-dose) quantities, will be 3004.90.9190, Harmonized Tariff of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which are administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 1-888-443-6332. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
Ruling history
More rulings on the same tariff codes
The tariff classification of Metformin Hydrochloride Extended Release Tablets in dosage form, from India
The tariff classification of Sodium Phenylacetate and Sodium Benzoate injection vials in dosage form, from India
The tariff classification, country of origin and country of origin marking of the AUGMENT® Bone Graft Kit from the United Kingdom and the applicability of subheading 9801.00.10, HTSUS
The tariff classification of GRASTEK® and RAGWITEK® sublingual tablets in dosage form, from Denmark
The tariff classification of Glyburide Tablets and Glyburide-Metformin Hydrochloride Tablets in dosage form, from India
The tariff classification of Voriconazole Tablets and Nateglinide Tablets in dosage form, from Malta and India, respectively
The tariff classification of Zolderonic Acid Injection in dosage form, from India
The tariff classification of Zoledronic Acid Injections in dosage form, from Austria
The tariff classification, country of origin marking of KANUMA™ (sebelipase alfa) in dosage form and the applicability of subheading 9801.00.10, HTSUS
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
Follow R03127
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.